New LDN website

[Guest guest]

Dear Friends,Below is a new LDN site that could use our stories. Please take a moment to check out.Best Regards,Destinyhttp://www.ldnscience.org/LDNscience™ is a public information project of the MedInsight® Research Institute.

The MedInsight® Research Institute is a

U.S.-based 501©(3) nonprofit working to bridge the ever-widening gap

between medical research and actual medical practice. We are dedicated

to bringing relief to those who suffer from cancer or chronic medical

conditions by raising awareness of:

• Commercially unsponsored medications. • Off-label or secondary uses for approved medications. • Specialized tests that enable treatments to be tailored to the individual.

MedInsight's founder, Moshe Rogosnitzky, is an expert in the clinical application of Low Dose Naltrexone (LDN), Opioid Growth Factor (OGF)

and related therapies, which have made incredible inroads with Crohn’s

disease, cancer and other serious diseases. He collaborates in research

with the discoverers of LDN and OGF, Dr. Ian S. Zagon and Dr. J. McLaughlin of Hershey Medical Center, Penn State University, as well as with Dr. Jill P. of Hershey Medical Center, who conducts clinical research into LDN and OGF.

This site is intended to provide you with general information on the background, use of and evidence for LDN, OGF

and related therapies, and to answer any questions on these therapies

and our work. If you cannot find the answer to your particular

question, please submit your question and we will respond to you as soon as possible.

To become a much-valued supporter of this site or of our life-changing research into LDN, OGF and related therapies, please visit: Join Our Supporters.

Thank you,

The LDNscienceâ„¢ Team